DNLI EBITDA Growth
Denali Therapeutics Inc · EBITDA Growth
DNLI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.50%period ending
DNLI TTM EBITDA YoY % (-7.93% → -6.50%)
Year-over-year change
High-resolution chart · PNG
DNLI ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -6.5032% | |
| -11.3816% | |
| -12.234% | |
| -8.1315% | |
| -5.9356% | |
| -179.4483% | |
| -245.7382% | |
| -324.7488% | |
| -302.1017% | |
| 54.9026% | |
| 59.2924% | |
| 64.1052% | |
| 60.2082% | |
| -26.7879% | |
| -11.2232% | |
| -914.2103% | |
| -555.1105% | |
| -562.9902% | |
| -498.24% | |
| 115.6941% | |
| 127.4441% | |
| 126.9101% | |
| 134.7229% | |
| -218.6299% | |
| -269.7361% | |
| -311.5825% | |
| -426.7166% | |
| 47.8432% | |
| 52.0623% | |
| 40.4348% | |
| 55.2517% | |
| -66.3861% | |
| -43.0683% | |
| -8.9018% | |
| -7.9267% |